Table 2.
Changes in cardiac and liver T2* MRI and serum ferritin at baseline and at 12 months in each group
| Liver MRI T2* (ms) | Cardiac MRI T2* (ms) | Ferritin (ng/ml) |
Variable
Group |
||||
|---|---|---|---|---|---|---|---|
| 12 month | Baseline | 12 month | Baseline | 12 month | Baseline | ||
| 6.2±9.5 | 5.5±6.6 | 13.5±8.4 | 12.0±4.1 | 2974±2894 | 2794±2310 | Mean±SD | Deferoxamine |
| 0.72 | 0.10 | 0.32 | P- value | ||||
| 4.9±5.3 | 3.4±3.1 | 17.5±7.1 | 13.0±4.5 | 2488±2088 | 3112±2549 | Mean±SD | Deferasirox |
| 0.01 | <0.001 | 0.005 | P- value | ||||
| 7.7±9.5 | 4.8±5.1 | 16.8±9.9 | 11.6±3.8 | 2681±2281 | 2817±2134 | Mean±SD | Deferoxamine +Deferiprone |
| 0.005 | 0.001 | 0.29 | P- value | ||||